Vagus nerve stimulation modulates distinct acetylcholine receptors on B cells and limits the germinal center response.
Izumi KurataIbrahim T MughrabiMinakshi RanaMichael GerberYousef Al-AbedBarbara SherryStavros ZanosBetty DiamondPublished in: Science advances (2024)
Acetylcholine is produced in the spleen in response to vagus nerve activation; however, the effects on antibody production have been largely unexplored. Here, we use a chronic vagus nerve stimulation (VNS) mouse model to study the effect of VNS on T-dependent B cell responses. We observed lower titers of high-affinity IgG and fewer antigen-specific germinal center (GC) B cells. GC B cells from chronic VNS mice exhibited altered mRNA and protein expression suggesting increased apoptosis and impaired plasma cell differentiation. Follicular dendritic cell (FDC) cluster dispersal and altered gene expression suggested poor function. The absence of acetylcholine-producing CD4 + T cells diminished these alterations. In vitro studies revealed that α7 and α9 nicotinic acetylcholine receptors (nAChRs) directly regulated B cell production of TNF, a cytokine crucial to FDC clustering. α4 nAChR inhibited coligation of CD19 to the B cell receptor, presumably decreasing B cell survival. Thus, VNS-induced GC impairment can be attributed to distinct effects of nAChRs on B cells.
Keyphrases
- gene expression
- mouse model
- dendritic cells
- single cell
- gas chromatography
- oxidative stress
- drug induced
- rheumatoid arthritis
- dna methylation
- endoplasmic reticulum stress
- regulatory t cells
- binding protein
- transcription factor
- high fat diet induced
- immune response
- cell cycle arrest
- type diabetes
- signaling pathway
- insulin resistance
- skeletal muscle
- endothelial cells
- high resolution
- wild type